Proteomics on malignant pleural effusions reveals ERα loss in metastatic breast cancer associates with SGK1–NDRG1 deregulation

Overcoming Endocrine Resistance in Breast Cancer

(2020) Ariella B. Hanker et al.   CANCER CELL

Estrogen Receptor on the move: Cistromic plasticity and its implications in breast cancer

(2020) Isabel Mayayo-Peralta et al.   MOLECULAR ASPECTS OF MEDICINE

Allele-Specific Chromatin Recruitment and Therapeutic Vulnerabilities of ESR1 Activating Mutations

(2018) Rinath Jeselsohn et al.   CANCER CELL

FOXA1 levels are decreased in pleural breast cancer metastases after adjuvant endocrine therapy, and this is associated with poor outcome

(2018) Willemijne Schrijver et al.   Molecular Oncology

Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2018) Freddie Bray et al.   CA-A CANCER JOURNAL FOR CLINICIANS

The Genomic Landscape of Endocrine-Resistant Advanced Breast Cancers

(2018) Pedram Razavi et al.   CANCER CELL

Glucocorticoid Receptor:MegaTrans Switching Mediates the Repression of an ERα-Regulated Transcriptional Program

(2017) Feng Yang et al.   MOLECULAR CELL

20-Year Risks of Breast-Cancer Recurrence after Stopping Endocrine Therapy at 5 Years

(2017) Hongchao Pan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Combating subclonal evolution of resistant cancer phenotypes

(2017) Samuel W. Brady et al.   Nature Communications

Loss of steroid hormone receptors is common in malignant pleural and peritoneal effusions of breast cancer patients treated with endocrine therapy

(2017) Willemijne A.M.E. Schrijver et al.   Oncotarget

Prognostic Impact of Discordance in Hormone Receptor Status Between Primary and Recurrent Sites in Patients With Recurrent Breast Cancer

(2016) Sho Shiino et al.   Clinical Breast Cancer

PlasmaESR1Mutations and the Treatment of Estrogen Receptor–Positive Advanced Breast Cancer

(2016) Charlotte Fribbens et al.   JOURNAL OF CLINICAL ONCOLOGY

Robust, Sensitive, and Automated Phosphopeptide Enrichment Optimized for Low Sample Amounts Applied to Primary Hippocampal Neurons

(2016) Harm Post et al.   JOURNAL OF PROTEOME RESEARCH

Genomic modelling of the ESR1 Y537S mutation for evaluating function and new therapeutic approaches for metastatic breast cancer

(2016) A Harrod et al.   ONCOGENE

ActivatingESR1Mutations Differentially Affect the Efficacy of ER Antagonists

(2016) Weiyi Toy et al.   Cancer Discovery

Prevalence of ESR1 Mutations in Cell-Free DNA and Outcomes in Metastatic Breast Cancer

(2016) Sarat Chandarlapaty et al.   JAMA Oncology

Progesterone receptor modulates ERα action in breast cancer

(2015) Hisham Mohammed et al.   NATURE

EpCAM expression varies significantly and is differentially associated with prognosis in the luminal B HER2+, basal-like and HER2 intrinsic subtypes of breast cancer

(2013) S D Soysal et al.   BRITISH JOURNAL OF CANCER

The role of NDRG1 in the pathology and potential treatment of human cancers

(2013) Dong-Hun Bae et al.   JOURNAL OF CLINICAL PATHOLOGY

ESR1 ligand-binding domain mutations in hormone-resistant breast cancer

(2013) Weiyi Toy et al.   NATURE GENETICS

Activating ESR1 mutations in hormone-resistant metastatic breast cancer

(2013) Dan R Robinson et al.   NATURE GENETICS

N-myc Downstream Regulated 1 (NDRG1) Is Regulated by Eukaryotic Initiation Factor 3a (eIF3a) during Cellular Stress Caused by Iron Depletion

(2013) Darius J. R. Lane et al.   PLoS One

Phosphorylation of NDRG1 is temporally and spatially controlled during the cell cycle

(2011) Catherine McCaig et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

MissForest--non-parametric missing value imputation for mixed-type data

(2011) D. J. Stekhoven et al.   BIOINFORMATICS

Bp44mT: an orally active iron chelator of the thiosemicarbazone class with potent anti-tumour efficacy

(2011) Y Yu et al.   BRITISH JOURNAL OF PHARMACOLOGY

Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1

(2011) Jessica L L Robinson et al.   EMBO JOURNAL

Clinical implications of activated leukocyte cell adhesion molecule expression in breast cancer

(2011) Daxun Piao et al.   MOLECULAR BIOLOGY REPORTS

mProphet: automated data processing and statistical validation for large-scale SRM experiments

(2011) Lukas Reiter et al.   NATURE METHODS

Identification of sites subjected to serine/threonine phosphorylation by SGK1 affecting N-myc downstream-regulated gene 1 (NDRG1)/Cap43-dependent suppression of angiogenic CXC chemokine expression in human pancreatic cancer cells

(2010) Yuichi Murakami et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS